Logo for Biora Therapeutics Inc

Biora Therapeutics Investor Relations Material

Latest events

Logo for Biora Therapeutics Inc

Q3 2023

Biora Therapeutics
Logo for Biora Therapeutics

Q3 2023

13 Nov, 2023
Logo for Biora Therapeutics

Q2 2023

14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Biora Therapeutics, Inc engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. Biora Therapeutics Inc operates as a subsidiary of Progenity Technologies Ltd.